Cerebral Pseudoatrophy or Real Atrophy After Therapy in Multiple Sclerosis

被引：19

作者：

Khoury, Samia ^{[1
]}

Bakshi, Rohit ^{[2
]}

机构：

[1] Brigham & Womens Hosp, Ctr Neurol Dis, Dept Neurol, Boston, MA 02115 USA

[2] Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Neurol, Boston, MA 02115 USA

来源：

ANNALS OF NEUROLOGY | 2010年 / 68卷 / 06期

关键词：

STEM-CELL TRANSPLANTATION; BRAIN ATROPHY; RELAPSING MS;

D O I：

10.1002/ana.22254

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

引用

页码：778 / 779

页数：2

共 13 条

[1] The measurement and clinical relevance of brain atrophy in multiple sclerosis [J].

Bermel, RA ;

Bakshi, R .

LANCET NEUROLOGY, 2006, 5 (02) :158-170

[2] Brain atrophy after immunoablation and stem cell transplantation in multiple sclerosis [J].

Chen, J. T. ;

Collins, D. L. ;

Atkins, H. L. ;

Freedman, M. S. ;

Galal, A. ;

Arnold, D. L. .

NEUROLOGY, 2006, 66 (12) :1935-1937

[3] Early development of multiple sclerosis is associated with progressive grey matter atrophy in patients presenting with clinically isolated syndromes [J].

Dalton, CM ;

Chard, DT ;

Davies, GR ;

Miszkiel, KA ;

Altmann, DR ;

Fernando, K ;

Plant, GT ;

Thompson, AJ ;

Miller, DH .

BRAIN, 2004, 127 :1101-1107

[4] Brain atrophy and magnetization transfer ratio following methylprednisolone in multiple sclerosis: short-term changes and long-term implications [J].

Fox, RJ ;

Fisher, E ;

Tkach, J ;

Lee, JC ;

Cohen, JA ;

Rudick, RA .

MULTIPLE SCLEROSIS JOURNAL, 2005, 11 (02) :140-145

[5] Interferon-β-1b slows progression of atrophy in RRMS -: Three-year follow-up in NAb- and NAb+ patients [J].

Frank, JA ;

Richert, N ;

Bash, C ;

Stone, L ;

Calabresi, PA ;

Lewis, B ;

Stone, R ;

Howard, T ;

Mcfarland, HF .

NEUROLOGY, 2004, 62 (05) :719-725

[6] Rate of brain atrophy in relapsing MS decreases during treatment with IFNβ-1a [J].

Hardmeier, M ;

Wagenpfeil, S ;

Freitag, P ;

Fisher, E ;

Rudick, RA ;

Kooijmans, M ;

Clanet, M ;

Radue, EW ;

Kappos, L .

NEUROLOGY, 2005, 64 (02) :236-240

[7] Sample size requirements for treatment effects using gray matter, white matter and whole brain volume in relapsing-remitting multiple sclerosis [J].

Healy, B. ;

Valsasina, P. ;

Filippi, M. ;

Bakshi, R. .

JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2009, 80 (11) :1218-1223

[8]

Inglese M, 2004, J NEUROL NEUROSUR PS, V75, P643

[9] MRI outcomes in a placebo-controlled trial of natalizumab in relapsing MS [J].

Miller, D. H. ;

Soon, D. ;

Fernando, K. T. ;

MacManus, D. G. ;

Barker, G. J. ;

Yousry, T. A. ;

Fisher, E. ;

O'Connor, P. W. ;

Phillips, J. T. ;

Polman, C. H. ;

Kappos, L. ;

Hutchinson, M. ;

Havrdova, E. ;

Lublin, F. D. ;

Giovannoni, G. ;

Wajgt, A. ;

Rudick, R. ;

Lynn, F. ;

Panzara, M. A. ;

Sandrock, A. W. .

NEUROLOGY, 2007, 68 (17) :1390-1401

[10] Multislice brain myelin water fractions at 3T in multiple sclerosis [J].

Oh, Joonmi ;

Han, Eric T. ;

Lee, Michael C. ;

Nelson, Sarah J. ;

Pelletier, Daniel .

JOURNAL OF NEUROIMAGING, 2007, 17 (02) :156-163

← 1 2 →